Bridging the gap between raw natural compounds and FDA-aligned clinical research endpoints for researchers, clinical sites, and supplement developers across Greater Houston.
Anchored by the world's largest medical complex, the Houston metropolitan area is rapidly transitioning into a premier global hub for integrative oncology, metabolic research, and translational natural therapeutics.
With institutions such as MD Anderson Cancer Center, Baylor College of Medicine, and UTHealth Houston, local clinical trials demand stringent chemistry, manufacturing, and control (CMC) packages. When botanical active substances enter local trials, analytical method establishment must ensure unwavering batch reproducibility and verifiable metabolic profiles.
The Port of Houston operates as the top foreign waterborne tonnage gateway in the U.S. Importing crude natural botanicals and active pharmaceutical ingredients (APIs) requires rigorous port-of-entry analytical assays—specifically to prevent heavy metal, solvent, and pesticide contamination under strict cGMP enforcement.
Texas's patient base increasingly demands evidence-based natural remedies for chronic disease prevention, post-chemotherapy adjunctive support, and metabolic syndrome control. Transitioning traditional formulas into licensed therapeutic hospital preparations requires chromatographic fingerprinting and rigorous toxicity screening.
Pharma procurement teams worldwide face identical roadblocks: seasonal botanical variations, fluctuating potency, supply chain disruptions, and rigorous regulatory scrutiny from the FDA, EMA, and NMPA.
Phytochemical concentrations fluctuate drastically based on altitude, soil composition, and harvesting time. Our analytical labs utilize HPTLC and HPLC fingerprinting to evaluate raw harvest batches across multiple origins, creating predictive potency profiles that de-risk long-term commercial contracting.
Many bioactive botanicals lack documented compendial assay methods. We establish custom HPLC, GC, LC-MS/MS, and spectroscopic methodologies with end-to-end validation under ICH guidelines—testing for linearity, specificity, precision, accuracy, and limits of quantitation (LOQ).
Laboratory success often fails at the pilot stage. Operating with proprietary pilot facilities and certified extraction infrastructures, our scientific team guarantees that parameters identified in the laboratory scale translate seamlessly to 100kg-plus commercial outputs without thermal degradation or solvent residue.
From artificial intelligence modeling to continuous spectroscopic monitoring, discover how modern analytical chemistry is accelerating botanical drug discovery.
Employing molecular docking models to predict target bindings for plant polysaccharides, polyphenols, and terpenes before initiating bench testing. This shortens the screening period by up to 60%.
Integrating green analytical chemistry (SFC and UPLC) with ultra-low solvent consumption to achieve high-resolution enantiomer separation of labile bioactive botanical molecules.
Connecting Houston's diverse clinical patient cohorts with real-time biometric and pharmacokinetic biomarker assays to evaluate functional botanical formulations for immune and metabolic indications.
Meeting United States Pharmacopeia (USP), FDA 21 CFR Part 111/211, and European Pharmacopoeia (Ph. Eur.) guidelines for cross-border biopharma transactions.
Formula structures, extraction parameters, and analytical protocols remain strictly guarded under bilateral Non-Disclosure Agreements (NDAs). Proprietary methodologies are developed exclusively for client filing portfolios.
We provide complete technical dossiers for Investigational New Drug (IND) applications, New Dietary Ingredient (NDI) notifications, and Generally Recognized as Safe (GRAS) certifications with full analytical records.
Each analytical validation encompasses screening for residual solvents (USP <467>), elemental contaminants by ICP-MS (USP <232>/<233>), pesticide residues (USP <561>), and micro-organism limits.
Common inquiries surrounding analytical methods, botanical contract research, and clinical trials for the Houston and US biopharma ecosystem.
Discover our complete range of certified services, spanning active discovery, chromatographic analysis, toxicity studies, and scaled finished dose manufacturing.
Whether your goal is advancing an oncology candidate into Phase I clinical trials in Houston or standardizing a botanical dietary formulation for nationwide launch, our scientific team is ready to assist.